Biomarkers: Technologies and Global Markets
June 01, 2011
Wellesley, Mass. – According to a new technical market research report, BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS (BIO061B) from BCC Research (www.bccresearch.com), the value of the global market for biomarkers was nearly $13.5 billion in 2010, but is expected to increase to nearly $33.3 billion in 2015, for a five-year compound annual growth rate (CAGR) of 19.8%.
The largest segment of the market, genomics, is projected to increase at a CAGR of 26.9% to nearly $17 billion in 2015, after being valued at an estimated $5.1 billion in 2010.
The second-largest segment, imaging, is estimated at $4.2 billion in 2010, but is expected to increase at a CAGR of 14.8% to $8.4 billion in 2015.
The proteomics segment will increase in value from $1.8 billion in 2010 to nearly $3.5 billion in 2015, for a CAGR of 13.5%.
The bioinformatics segment will increase at a CAGR of 19.3%, rising from $1.1 billion in 2010 to $2.6 billion in 2015.
This report is designed to provide a range of information, from detailed product analyses within disease subsegments to overall industry trends, in order to quantify and qualify the market for products and services in the biomarkers segment. Individual product-types are forecast on a global basis, as are overall segments.
The biomarkers market presents the largest of all opportunities in representative disease subsegments. This study investigates one of the most important market drivers: The introduction of combination therapies, which are expected to continue to contribute substantially to market growth through the forecast period.
Applications for biomarkers are wide-ranging, and will have a pivotal impact in medicine. Targeted therapies, improved patient selection for clinical trial criteria, early drug rationalization, and proactively identifying adverse events for patients are some of the leading applications for biomarkers currently and through the forecast period.
This report is an invaluable tool for business planners, acquisitions specialists, licensing strategists, product managers, market research analysts, investors, investor consultants and anyone interested in the biomarkers market, its products, its industry participants, and its future.
Biomarkers: Technologies and Global Markets( BIO061B )
Publish Date: Mar 2011
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Cell Biology
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development
Reports from Cell Biology
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum